4.7 Article

Prioritizing prognostic-associated subpopulations and individualized recurrence risk signatures from single-cell transcriptomes of colorectal cancer

Journal

BRIEFINGS IN BIOINFORMATICS
Volume 24, Issue 3, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbad078

Keywords

single-cell gene pair signatures; relative expression orderings; colorectal cancer; recurrence risk signatures

Ask authors/readers for more resources

Colorectal cancer (CRC) is a common gastrointestinal malignancy, but few recurrence risk signatures exist for these patients. In this study, a computational framework called scRank(XMBD) was proposed to prioritize prognostic-associated cell subpopulations based on within-cell relative expression orderings of gene pairs from single-cell transcriptomes. The results of this study facilitate the application of rank-based methods in cancer genomics and precision oncology.
Colorectal cancer (CRC) is one of the most common gastrointestinal malignancies. There are few recurrence risk signatures for CRC patients. Single-cell RNA-sequencing (scRNA-seq) provides a high-resolution platform for prognostic signature detection. However, scRNA-seq is not practical in large cohorts due to its high cost and most single-cell experiments lack clinical phenotype information. Few studies have been reported to use external bulk transcriptome with survival time to guide the detection of key cell subtypes in scRNA-seq data. We proposed scRank(XMBD), a computational framework to prioritize prognostic-associated cell subpopulations based on within-cell relative expression orderings of gene pairs from single-cell transcriptomes. scRank(XMBD) achieves higher precision and concordance compared with five existing methods. Moreover, we developed single-cell gene pair signatures to predict recurrence risk for patients individually. Our work facilitates the application of the rank-based method in scRNA-seq data for prognostic biomarker discovery and precision oncology. scRank(XMBD) is available at . (XMBD:Xiamen Big Data, a biomedical open software initiative in the National Institute for Data Science in Health and Medicine, Xiamen University, China.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available